Copyright
©The Author(s) 2017.
World J Clin Oncol. Jun 10, 2017; 8(3): 266-272
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.266
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.266
Figure 2 Funnel plots of randomized clinical trials comparing surgery alone or with additional chemotherapy for the treatment of patients with potentially resectable colorectal liver metastases.
The HR was fit for overall survival. HR: Hazard ratio.
- Citation: Araujo RLC, Herman P, Riechelmann RP. Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review. World J Clin Oncol 2017; 8(3): 266-272
- URL: https://www.wjgnet.com/2218-4333/full/v8/i3/266.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i3.266